Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GoHealth (GOCO) EBIT (2019 - 2025)

GoHealth (GOCO) has disclosed EBIT for 7 consecutive years, with -$32.3 million as the latest value for Q4 2025.

  • Quarterly EBIT fell 140.2% to -$32.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$412.9 million through Dec 2025, down 5759.25% year-over-year, with the annual reading at -$412.9 million for FY2025, 5759.25% down from the prior year.
  • EBIT hit -$32.3 million in Q4 2025 for GoHealth, up from -$287.9 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $80.3 million in Q4 2024 to a low of -$423.2 million in Q4 2021.
  • Historically, EBIT has averaged -$65.5 million across 5 years, with a median of -$39.3 million in 2023.
  • Biggest five-year swings in EBIT: plummeted 5416.28% in 2021 and later skyrocketed 432.98% in 2024.
  • Year by year, EBIT stood at -$423.2 million in 2021, then skyrocketed by 68.53% to -$133.2 million in 2022, then soared by 111.31% to $15.1 million in 2023, then surged by 432.98% to $80.3 million in 2024, then crashed by 140.2% to -$32.3 million in 2025.
  • Business Quant data shows EBIT for GOCO at -$32.3 million in Q4 2025, -$287.9 million in Q3 2025, and -$99.4 million in Q2 2025.